Illumina 's board on Tuesday named Jacob Thaysen the DNA sequencing company's new CEO as it tries to rebound from a grinding dispute over its acquisition of cancer test developer Grail.
Thaysen, a 48-year-old longtime executive at medical devices firm Agilent , will step in as CEO on Sept. 25.
His nomination comes months after a bitter proxy fight with activist investor Carl Icahn ended with Illumina's former CEO Francis deSouza resigning despite securing enough votes to stay.
"Jacob's unique combination of deep technological and commercial experience will be a great addition to Illumina," Stephen MacMillan, the chair of Illumina's board, said in the release.
Thaysen will take over for Charles Dadswell, who has been serving as Illumina's interim CEO since June.
Persons:
Illumina, Jacob Thaysen, Carl Icahn, Francis deSouza, Icahn, Thaysen, Stephen MacMillan, Charles Dadswell, Dadswell
Organizations:
Union, European Commission, U.S . Federal Trade Commission, Illumina
Locations:
Illumina, San Diego , California, U.S, Agilent